TY - JOUR
T1 - Directed Evolution Strategies for Enantiocomplementary Haloalkane Dehalogenases
T2 - From Chemical Waste to Enantiopure Building Blocks
AU - van Leeuwen, Jan G. E.
AU - Wijma, Hein J.
AU - Floor, Robert J.
AU - van der Laan, Jan-Metske
AU - Janssen, Dick B.
PY - 2012/1/2
Y1 - 2012/1/2
N2 - We used directed evolution to obtain enantiocomplementary haloalkane dehalogenase variants that convert the toxic waste compound 1,2,3-trichloropropane (TCP) into highly enantioenriched (R)- or (S)-2,3-dichloropropan-1-ol, which can easily be converted into optically active epichlorohydrinsattractive intermediates for the synthesis of enantiopure fine chemicals. A dehalogenase with improved catalytic activity but very low enantioselectivity was used as the starting point. A strategy that made optimal use of the limited capacity of the screening assay, which was based on chiral gas chromatography, was developed. We used pair-wise site-saturation mutagenesis (SSM) of all 16 noncatalytic active-site residues during the initial two rounds of evolution. The resulting best R- and S-enantioselective variants were further improved in two rounds of site-restricted mutagenesis (SRM), with incorporation of carefully selected sets of amino acids at a larger number of positions, including sites that are more distant from the active site. Finally, the most promising mutations and positions were promoted to a combinatorial library by using a multi-site mutagenesis protocol with restricted codon sets. To guide the design of partly undefined (ambiguous) codon sets for these restricted libraries we employed structural information, the results of multiple sequence alignments, and knowledge from earlier rounds. After five rounds of evolution with screening of only 5500 clones, we obtained two strongly diverged haloalkane dehalogenase variants that give access to (R)-epichlorohydrin with 90?% ee and to (S)-epichlorohydrin with 97?% ee, containing 13 and 17 mutations, respectively, around their active sites.
AB - We used directed evolution to obtain enantiocomplementary haloalkane dehalogenase variants that convert the toxic waste compound 1,2,3-trichloropropane (TCP) into highly enantioenriched (R)- or (S)-2,3-dichloropropan-1-ol, which can easily be converted into optically active epichlorohydrinsattractive intermediates for the synthesis of enantiopure fine chemicals. A dehalogenase with improved catalytic activity but very low enantioselectivity was used as the starting point. A strategy that made optimal use of the limited capacity of the screening assay, which was based on chiral gas chromatography, was developed. We used pair-wise site-saturation mutagenesis (SSM) of all 16 noncatalytic active-site residues during the initial two rounds of evolution. The resulting best R- and S-enantioselective variants were further improved in two rounds of site-restricted mutagenesis (SRM), with incorporation of carefully selected sets of amino acids at a larger number of positions, including sites that are more distant from the active site. Finally, the most promising mutations and positions were promoted to a combinatorial library by using a multi-site mutagenesis protocol with restricted codon sets. To guide the design of partly undefined (ambiguous) codon sets for these restricted libraries we employed structural information, the results of multiple sequence alignments, and knowledge from earlier rounds. After five rounds of evolution with screening of only 5500 clones, we obtained two strongly diverged haloalkane dehalogenase variants that give access to (R)-epichlorohydrin with 90?% ee and to (S)-epichlorohydrin with 97?% ee, containing 13 and 17 mutations, respectively, around their active sites.
KW - directed evolution
KW - enantiocomplementarity
KW - enantioselectivity
KW - haloalkane dehalogenases
KW - protein engineering
KW - stereoselectivity
KW - ITERATIVE SATURATION MUTAGENESIS
KW - STRUCTURE-GUIDED RECOMBINATION
KW - IN-VITRO RECOMBINATION
KW - LABORATORY EVOLUTION
KW - FLUORESCENS ESTERASE
KW - KINETIC RESOLUTION
KW - ENZYME EVOLUTION
KW - ACCESS TUNNELS
KW - BINDING-SITE
KW - ENANTIOSELECTIVITY
U2 - 10.1002/cbic.201100579
DO - 10.1002/cbic.201100579
M3 - Article
SN - 1439-4227
VL - 13
SP - 137
EP - 148
JO - ChemBioChem
JF - ChemBioChem
IS - 1
ER -